id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-D-0563-0003,FDA,FDA-2022-D-0563,"Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Small Entity Compliance Guide; Guidance for Industry",Other,Guidance,2022-11-01T04:00:00Z,2022,11,2022-11-01T04:00:00Z,,2024-11-12T23:47:12Z,,1,0,0900006485478522
FDA-2022-D-0563-0002,FDA,FDA-2022-D-0563,"Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Small Entity Compliance Guide; Availability",Rule,Final Rule,2022-11-01T04:00:00Z,2022,11,2022-11-01T04:00:00Z,,2022-11-01T12:02:22Z,2022-23573,0,0,0900006485477077
FDA-2022-D-0563-0001,FDA,FDA-2022-D-0563,"Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT Ps) - Small Entity Compliance Guide",Other,Guidance,2022-04-07T04:00:00Z,2022,4,2022-04-07T04:00:00Z,,2022-11-01T14:48:25Z,,0,0,090000648460e2ba